hOver the last few yeats, many studies have been carried out in order
to individualize which nonsteroidal anti-inflammatory drug (NSAID) can
be tolerated in aspirin sensitivity. Imidazole salicylate (IS) is a n
ew NSAID that inhibits Tromboxane A(2) synthesis, without interferring
with cyclo-oxygenase pathway, whose inhibition was demonstrated to ca
use asthma and/or urticaria/angioedema in aspirin-sensitive patients.
We enrolled 67 subjects with documented intolerance to aspirin, pyrazo
lones or NSAIDs, clinically, manifested as urticaria/angioedema (68%),
asthma, and/or rhinitis (32%). A challenge with IS was carried out in
every patient in single-blind fashion, reaching a cumulative dosage o
f 1000 mg in the fourth session. No appearance of urticaria or broncho
spastic reactions was registered in any subject, confirming the safe u
se of IS in aspirin-sensitive patients.